Table 1.
Patient Demographics and Tumor Characteristics by Treatment Choice (N = 240)
| Variable | Surgery n = 137 | Radiation n = 72 | WW/AS n = 31 | P value |
|---|---|---|---|---|
| Age, mean (SD) | 59.4 (7.4) | 63.2 (7.2) | 64.3 (7.9) | <.001 |
| Age group, No. (%) | .002 | |||
| ≤65 | 102 (74.5) | 41 (56.9) | 14 (45.2) | |
| >65 | 35 (25.5) | 31 (43.1) | 17 (54.8) | |
| Race, No. (%) | .81 | |||
| Black | 68 (49.6) | 36 (50.0) | 17 (54.8) | |
| White | 69 (50.4) | 36 (50.0) | 14 (45.2) | |
| Education, No. (%) | .70 | |||
| ≤High school | 46 (34.1) | 25 (35.2) | 11 (35.5) | |
| Some college | 37 (27.4) | 27 (38.0) | 10 (32.3) | |
| College graduate | 27 (20.0) | 11 (15.5) | 5 (16.1) | |
| Some postgraduate study | 25 (18.5) | 8 (11.3) | 5 (16.1) | |
| No. comorbidities, mean (SD) | 1.23 (1.0) | 1.75 (1.3) | 1.39 (1.0) | .01 |
| General health perception, mean (SD) | 2.71 (0.84) | 2.41 (0.89) | 2.26 (0.89) | .008 |
| Perceived cancer seriousness, mean (SD) | 3.8 (1.3) | 3.1 (1.3) | 2.9 (1.4) | <.001 |
| Worry about prostate cancer, mean (SD) | 2.5 (1.0) | 2.1 (0.9) | 2.4 (1.0) | .004 |
| PSA level, No. (%) | .39 | |||
| ≤4 | 36 (26.9) | 22 (31.0) | 8 (28.6) | |
| 5–9 | 80 (59.7) | 41 (57.7) | 15 (53.6) | |
| 10–19 | 15 (11.2) | 4 (5.6) | 5 (17.9) | |
| ≥20 | 3 (2.2) | 4 (5.6) | 0 (0.0) | |
| Gleason score, No. (%) | .03 | |||
| ≤6 | 48 (35.3) | 30 (46.2) | 15 (50.0) | |
| 7 | 79 (58.1) | 25 (38.5) | 11 (36.7) | |
| 8–10 | 9 (6.6) | 10 (15.4) | 4 (13.3) | |
| Stage, No. (%) | <.001 | |||
| ≤T2a | 21 (15.4) | 51 (78.5) | 23 (76.7) | |
| T2b or T2NOS | 19 (14.0) | 8 (12.3) | 5 (16.7) | |
| ≥T2c | 96 (70.6) | 6 (9.2) | 2 (6.7) | |
| Risk level, No. (%) | <.001 | |||
| Low risk | 8 (5.9) | 26 (40.0) | 9 (30.0) | |
| Intermediate risk | 29 (21.3) | 23 (35.4) | 15 (50.0) | |
| High risk | 99 (72.8) | 16 (24.6) | 6 (20.0) |
PSA = prostate-specific antigen; WW/AS = watchful waiting or active surveillance.
Note: The general health perceptions scale ranged from 1 (Poor) to 5 (Excellent), the perceived cancer seriousness scale ranged from 1 (Not at all Serious) to 5 (Very Serious), and the worry about prostate cancer scale ranged from 1 (Not at all) to 4 (Very Much).